Dakota Wealth Management
DMAA icon

Dakota Wealth Management’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Dakota Wealth Management’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Hold
36,400
– – 0.01% 621
2026
Q1 		$381K Hold
36,400
– – 0.01% 604
2025
Q4 		$377K Hold
36,400
– – 0.01% 605
2025
Q3 		$374K Buy
+36,400
New +$373K 0.01% 524

Other funds holding DMAA

Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
Mizuho Securities USA
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
First Trust Capital Management
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Heights Capital Management
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Dakota Wealth Management's DMAA Position: Q2 2026 in Review

Dakota Wealth Management held its Drugs Made In America Acquisition Corp (DMAA) position steady in Q2 2026 at 36,400 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #621.

Dakota Wealth Management first reported a position in DMAA in Q3 2025 and has held it in 4 quarters since. 23 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • Dakota Wealth Management held 36,400 shares of Drugs Made In America Acquisition Corp worth $388K as of Q2 2026.
  • Dakota Wealth Management left its Drugs Made In America Acquisition Corp share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition Corp made up 0.01% of Dakota Wealth Management's portfolio in Q2 2026, its #621 holding.
  • Dakota Wealth Management first reported a position in Drugs Made In America Acquisition Corp in Q3 2025 and has held it in 4 quarters since.
  • 23 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.